Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T34734 |
Substance P (1-4)
SP(1-4) |
||
Substance P (1-4) is a substance P N-terminal tetrapeptide fragment. | |||
T81077 |
Substance P(1-4)
|
||
Substance P(1-4)为一有效的神经激肽受体(NK-R)拮抗剂,具有调节正常造血功能并抑制内源性红细胞集落(EEC)形成的能力。 | |||
T76483 |
[Sar4] Substance P (4-11)
|
||
[Sar4] Substance P (4-11)为Substance P (4-11)的类似物,后者是Substance P (Substance P) C端片段并充当Substance P激动剂。 | |||
T83495 |
[D-Pro4,D-Trp7,9] Substance P (4-11)
|
||
[D-Pro4,D-Trp7,9]Substance P(4-11)为高效Substance P 拮抗剂,可降低血浆醛固酮(ALDO)浓度。 | |||
T76447 |
[DAla4] Substance P (4-11)
|
||
[DAla4] Substance P (4-11) 作为Substance P的衍生物,能够有效抑制125I-Bolton Hunter标记的Eledoisin(IC50值为0.5 μM)及125I-Bolton Hunter标记的Substance P (IC50值为0.15 μM)与大鼠大脑皮层膜之间的结合。 | |||
T83496 |
[D-Pro4,D-Trp7,9,10] Substance P (4-11)
|
||
[D-Pro4,D-Trp7,9,10] Substance P (4-11) 是一种tachykinin拮抗剂,具有高效性。 | |||
T76406 |
[D-Pro4,D-Trp7,9,Nle11] Substance P (4-11)
|
||
[D-Pro4,D-Trp7,9,Nle11] Substance P (4-11) 为高效的神经激肽 NK1 拮抗剂,能够有效抑制金蛋白 P 物质 (GPSP) 与 P 物质 (SP) 的活性。 |